You are here:

Category: 13.5 Preparations for eczema and psoriasis

Name SMC ID No Manufacturer Status Sub. Type
 
adalimumab (Humira) 1243/17 AbbVie Ltd Accepted Abbreviated Submission
alitretinion (Toctino) 538/09 Basilea Pharmaceuticals Ltd Accepted Full submission
calcipotriol + betamethasone (Enstilar) 1182/16 LEO Pharmaceuticals Accepted Abbreviated Submission
calcipotriol 50 mcg/g / betamethasone 05 mg/g (Xamiol Gel®) 559/09 LEO Pharmaceuticals Accepted Full submission
Calcipotriol and betamethasone ointment (Dovobet®) 09/02 LEO Pharmaceuticals Restricted Resubmission
Calcipotriol and bethamethasone ointment (Dovobet®) 09/02 LEO Pharmaceuticals Not Recommended Full submission
Calcitriol 3ug/g for psoriasis (Silkis Ointment®) 43/03 Galderma (UK) Ltd Accepted Full submission
Efalizumab (Raptiva®) 146/04 Serono Ltd Marketing Authorisation Withdrawn Full submission
etanercept (Enbrel) 842/13 Pfizer Ltd Restricted Abbreviated Submission
etanercept (Enbrel) 570/09 Wyeth Pharmaceuticals Superseded Abbreviated Submission
golimumab (Simponi) 674/11 MSD Not Recommended Full submission
ixekizumab (Taltz) 1223/17 Eli Lilly and Company Ltd Restricted Full submission
pimecrolimus cream (Elidel®) 35/03 Novartis Pharmaceuticals UK Ltd Not Recommended IRP
pimecrolimus cream (Elidel®) 35/03 Novartis Pharmaceuticals UK Ltd Not Recommended Full submission
pimecrolimus cream (Elidel®) 35/03 Novartis Pharmaceuticals UK Ltd Not Recommended Resubmission
tacrolimus (Protopic) 608/10 Astellas Pharma Ltd Accepted Full submission
tacrolimus (Protopic) 0.1% ointment 609/10 Astellas Pharma Ltd Accepted Full submission
tacrolimus, 5mg/ml concentrate for infusion and 0.5mg, 1mg, 5mg hard capsules (Prograf) 346/07 Astellas Pharma Ltd Restricted Full submission
ustekinumab (Stelara) 572/09 Janssen-Cilag Ltd Restricted Full submission
ustekinumab (Stelara) 944/14 Janssen-Cilag Ltd Accepted Full submission

Back